PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
03-Feb-2026 Mercury Medical Awarded Vizient Contract for Disposable Manual Resuscitators and Accessories ACCESS Newswire
03-Feb-2026 Future-Ready EHR Vendor Rankings for Small and Critical Access Hospitals: Black Book Survey Highlights 2026 Outlook ACCESS Newswire
03-Feb-2026 BIO ESSENCE CORP (OTC Pink: BIOE) Announces Commencement of Regulation A Tier 2 Offering for up to $5.0 Million ACCESS Newswire
03-Feb-2026 Stemtech Corporation Welcomes Dr. Zahooruddin To Life Sciences Advisory Board ACCESS Newswire
03-Feb-2026 Aptevo Announces Executive Leadership Transitions to Support Next Phase of Growth ACCESS Newswire
03-Feb-2026 Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution ACCESS Newswire
03-Feb-2026 MIRA Pharmaceuticals Initiates Final Cohort of Ketamir-2 Phase 1 Clinical Study as Company Prepares for Phase 2a Study ACCESS Newswire
03-Feb-2026 CBD Life Sciences Inc. (CBDL) Announces Smoking Scholars Bronx Dispensary as Major Distributor for High-Demand Dubai Mushroom Chocolate ACCESS Newswire
03-Feb-2026 Lobe Sciences Reports First Quarter 2026 Results and Highlights ACCESS Newswire
03-Feb-2026 AlzeCure Abstract on NeuroRestore ACD856 accepted at the Alzheimer's conference AP/PD 2026 ACCESS Newswire
02-Feb-2026 The Micro-Mechanics of Modern Oral Care ACCESS Newswire
02-Feb-2026 SLAS Names PulpFixin(R) Official Sustainability Sponsor for Europe Conference in Vienna, Key Sustainability Supporter at SLAS2026 in Boston ACCESS Newswire
02-Feb-2026 CEO Statement to Shareholders ACCESS Newswire
02-Feb-2026 Rural Health Transformation Reality Check: What Rural Hospital Decision-Makers Will Fund in 2026 and What They Won't ACCESS Newswire
02-Feb-2026 NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres ACCESS Newswire
02-Feb-2026 IGC Pharma Reaches 70% Enrollment in Phase 2 CALMA Trial Evaluating IGC-AD1 for Alzheimer's Agitation ACCESS Newswire
02-Feb-2026 AlzeCure Pharma Selected to Present at the Bio-Neuroscience conference in Amsterdam ACCESS Newswire
02-Feb-2026 NHI Announces $105.5 Million SHOP Investment ACCESS Newswire
31-Jan-2026 AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research ACCESS Newswire
30-Jan-2026 Moolec Science Granted Continued Listing on Nasdaq Subject to Hearings Panel Conditions ACCESS Newswire